Larisa Rudenko

3.2k citations

166 papers · 2.2k indexed · h-index 25

Co-authors: Irina Isakova–Sivak Irina Kiseleva Svetlana Donina Daria Mezhenskaya Andrey Rekstin Daniil Korenkov Nancy J. Cox Victoria Matyushenko
Topics: Influenza Virus Research Studies (143 papers)Respiratory viral infections research (108 papers)SARS-CoV-2 and COVID-19 Research (32 papers)
Cited by: Epidemiology Infectious Diseases Agronomy and Crop Science
Journals: SHILAP Revista de lepidopterologíaPLoS ONE Clinical Infectious Diseases
Partner nations: Russia United States Czechia

In The Last Decade

Larisa Rudenko

147 papers receiving 2.2k citations

Peers

Countries citing papers authored by Larisa Rudenko

Since Specialization

Citations

This map shows the geographic impact of Larisa Rudenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larisa Rudenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larisa Rudenko more than expected).

Fields of papers citing papers by Larisa Rudenko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larisa Rudenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larisa Rudenko. The network helps show where Larisa Rudenko may publish in the future.

Co-authorship network of co-authors of Larisa Rudenko

This figure shows the co-authorship network connecting the top 25 collaborators of Larisa Rudenko. A scholar is included among the top collaborators of Larisa Rudenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larisa Rudenko. Larisa Rudenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Protective Potential and Functional Role of Antibodies Against SARS-CoV-2 Nucleocapsid Protein 2025 ·Antibodies ·(unknown),(unknown),(unknown),Victoria Matyushenko,(unknown),К. В. Сивак,(unknown),Larisa Rudenko,(unknown)	0
2	Development of Cross-Reactive Live Attenuated Influenza Vaccine Candidates against Both Lineages of Influenza B Virus 2024 ·Vaccines ·(unknown),(unknown),(unknown),(unknown),(unknown),Andrey Rekstin,Larisa Rudenko	5
3	Safety, Immunogenicity and Protective Activity of a Modified Trivalent Live Attenuated Influenza Vaccine for Combined Protection Against Seasonal Influenza and COVID-19 in Golden Syrian Hamsters 2024 ·Vaccines ·(unknown),Victoria Matyushenko,(unknown),(unknown),(unknown),(unknown),Svetlana Donina,(unknown),(unknown),(unknown),(unknown),(unknown),К. В. Сивак,(unknown),(unknown),Larisa Rudenko,Irina Isakova–Sivak	0
4	Nucleoprotein as a Promising Antigen for Broadly Protective Influenza Vaccines 2023 ·Vaccines ·(unknown),Irina Isakova–Sivak,Larisa Rudenko	10
5	Understanding the Variability of Certain Biological Properties of H1N1pdm09 Influenza Viruses 2022 ·Vaccines ·(unknown),Irina Kiseleva,(unknown),(unknown),L. V. Puchkova,Larisa Rudenko	8
6	Dysregulated Immune Responses in SARS-CoV-2-Infected Patients: A Comprehensive Overview 2022 ·Viruses ·Igor Kudryavtsev,Artem Rubinstein,А. С. Головкин,Olga Kalinina,(unknown),Larisa Rudenko,Irina Isakova–Sivak	28
7	Safety, Immunogenicity, and Protective Efficacy of a Chimeric A/B Live Attenuated Influenza Vaccine in a Mouse Model 2021 ·Microorganisms ·(unknown),(unknown),(unknown),Victoria Matyushenko,(unknown),Irina Isakova–Sivak,Larisa Rudenko	6
8	Construction of the vaccine strain of the influenza B virus with chimeric hemagglutinin to induce a cross-protective immune response 2021 ·Medical academic journal ·(unknown),(unknown),(unknown),(unknown),(unknown),Irina Isakova–Sivak,Larisa Rudenko	0
9	A Strategy to Elicit M2e-Specific Antibodies Using a Recombinant H7N9 Live Attenuated Influenza Vaccine Expressing Multiple M2e Tandem Repeats 2021 ·Biomedicines ·Daria Mezhenskaya,Irina Isakova–Sivak,(unknown),Victoria Matyushenko,Minchul Kim,(unknown),Ki‐Hye Kim,Sang‐Moo Kang,Larisa Rudenko	10
10	Anti-Influenza Effect of Nanosilver in a Mouse Model 2020 ·Vaccines ·Irina Kiseleva,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Larisa Rudenko,Massimo Broggini,L. V. Puchkova	14
11	Recombinant Live Attenuated Influenza Vaccine Viruses Carrying Conserved T Cell Epitopes of Human Adenoviruses Induce Functional Cytotoxic T Cell Responses and Protect Mice against both Infections 2020 ·Vaccines ·Irina Isakova–Sivak,Victoria Matyushenko,(unknown),(unknown),(unknown),Daria Mezhenskaya,(unknown),I. V. Kudryavtsev,(unknown),К. В. Сивак,Larisa Rudenko	12
12	A Phase 1 Randomized Placebo-Controlled Study to Assess the Safety, Immunogenicity and Genetic Stability of a New Potential Pandemic H7N9 Live Attenuated Influenza Vaccine in Healthy Adults 2020 ·Vaccines ·Irina Kiseleva,Irina Isakova–Sivak,Marina Stukova,(unknown),Svetlana Donina,Natalie Larionova,(unknown),(unknown),(unknown),(unknown),Victoria Matyushenko,(unknown),(unknown),(unknown),Dmitry Lioznov,Erin Sparrow,Guido Torelli,Larisa Rudenko	6
13	Non-Mouse-Adapted H1N1pdm09 Virus as a Model for Influenza Research 2020 ·Viruses ·Irina Kiseleva,Andrey Rekstin,(unknown),(unknown),(unknown),L. V. Puchkova,Larisa Rudenko	9
14	Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenza-specific resident memory T-cell responses 2020 ·Antiviral Research ·Victoria Matyushenko,(unknown),Igor Kudryavtsev,Daria Mezhenskaya,(unknown),(unknown),К. В. Сивак,(unknown),Larisa Rudenko,(unknown)	25
15	Evaluation of A(H1N1)pdm09 LAIV vaccine candidates stability and replication efficiency in primary human nasal epithelial cells 2019 ·Vaccine X ·(unknown),(unknown),P.J. Carney,(unknown),Natalie Larionova,Irina Kiseleva,Larisa Rudenko,Amrita Kumar,Cynthia S. Goldsmith,Vivien G. Dugan,James Stevens,David E. Wentworth,Tatiana Bousse	11
16	Basics of CD8 T-cell immune responses after influenza infection and vaccination with inactivated or live attenuated influenza vaccine 2018 ·Expert Review of Vaccines ·Daniil Korenkov,Irina Isakova–Sivak,Larisa Rudenko	48
17	Live attenuated influenza vaccine viral vector induces functional cytotoxic T-cell immune response against foreign CD8+ T-cell epitopes inserted into NA and NS1 genes using the 2A self-cleavage site 2018 ·Human Vaccines & Immunotherapeutics ·(unknown),Daniil Korenkov,Victoria Matyushenko,(unknown),Larisa Rudenko,Irina Isakova–Sivak	19
18	Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin 2018 ·Virology ·Irina Isakova–Sivak,Daniil Korenkov,(unknown),(unknown),Svetlana Donina,Victoria Matyushenko,Daria Mezhenskaya,Florian Krammer,Larisa Rudenko	32
19	Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model 2018 ·Infection Genetics and Evolution ·Daniil Korenkov,Karen Laurie,Patrick C. Reading,Louise Carolan,Kok Fei Chan,(unknown),(unknown),Kanta Subbarao,Ian Barr,Julie Villanueva,(unknown),Tatiana Bousse,Larisa Rudenko	12
20	APPLICATION OF METHOD BASED ON IN VITRO ANTIBODY QUANTIFICATION IN PBMC SUPERNATANT SAMPLES FOR IMMUNOGENICITY EVALUATION OF A (H5N1) AND A (H5N2) POTENTIALLY PANDEMIC INFLUENZA VACCINES IN CLINICAL TRIALS 2016 ·Medical Immunology (Russia) ·(unknown),Svetlana Donina,Galina Petukhova,(unknown),Larisa Rudenko,(unknown)	0

About Larisa Rudenko

Larisa Rudenko is a scholar working on Epidemiology, Infectious Diseases and Agronomy and Crop Science, having authored 166 papers that have together received 2.2k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (143 papers), Respiratory viral infections research (108 papers) and SARS-CoV-2 and COVID-19 Research (32 papers). The work is most often cited by research in Epidemiology (1.9k citations), Infectious Diseases (804 citations) and Agronomy and Crop Science (367 citations). Larisa Rudenko has collaborated with scholars based in Russia, United States and Czechia. Frequent co-authors include Irina Isakova–Sivak, Irina Kiseleva, Svetlana Donina, Daria Mezhenskaya, Andrey Rekstin, Daniil Korenkov, Nancy J. Cox, Victoria Matyushenko, Alexander Klimov and Natalie Larionova. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact